Ikonisys successfully obtains its ISO certification, reaffirming its ability to continuously meet the quality requirements of international standards
Paris, October 16, 2023 – 6:00 p.m. – Ikonisys SA (ISIN Code: FR00140048X2 / Ticker: ALIKO), a company specializing in the early and accurate detection of cancer using a unique, fully automated solution for medical diagnostic laboratories, announces today that its American subsidiary successfully passed the tri-annual renewal of its ISO audit.